Evidence map›Paper›PMID 23187133›Full record

ArticleThe Journal of clinical investigation2012

Mitochondrial heme: an exit strategy at last.

Mark D Fleming, Iqbal Hamza

Open access · bronzeAbstract readComment
In one paragraph

Article in The Journal of clinical investigation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Mechanisms of heme transport in the mitochondria.Biochemical Society transactions · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Mitoepigenetics and Its Emerging Roles in Cancer.Frontiers in cell and developmental biology · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Mark D FlemingDepartment of Pathology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. mark.fleming@childrens.harvard.edu
Iqbal Hamza
Boston Children's Hospital · USInstitute of Animal Sciences · CN

Funding

Molecular Genetics of Sideroblastic AnemiaR01DK087992 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI FLEMING, MARK D · 2011 to 2015
$2.0M
NIDDK NIH HHS R01 DK087992
6 · The paper itself

Abstract

The transport of heme across membranes is critical for iron absorption, the formation of hemoglobin and other hemoproteins, and iron recycling in macrophages. However, the identity of heme transport proteins has been elusive. In this issue of the JCI, Chiabrando et al. reveal that an isoform of the feline leukemia virus subgroup C receptor (FLVCR1) exports heme from the mitochondria and is critical for erythroid differentiation.

Indexed as

Cell DifferentiationAnimalsErythrocytesHumansMembrane Transport ProteinsMitochondrial ProteinsReceptors, VirusFLVCR1 protein, humanMembrane Transport ProteinsMitochondrial ProteinsReceptors, Virus

Identifiers

PMID23187133
PMCPMC3533263
OpenAlexW1982686390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.